Expert commentary on the importance of improving HCV treatment uptake in persons who inject drugs and effective linkage-to-care strategies
Expert commentary from Christopher Byrne and Dr. John Dillon on evaluating an HCV treatment as prevention (TasP) model for PWID in Tayside, Scotland
Linda M. Spooner, PharmD, BCPS, FASHP, FCCP, provides insights on how pharmacist medication therapy management expertise can improve HCV care
Audio commentary from Drs. Alessio Aghemo (Italy) and Karine Lacombe (France) with lessons from Europe on HCV treatment as prevention in PWID and others
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.